NSE: METROPOLIS
METROPOLIS HEALTHCARE LTD
Price history
+12.43% over 3M
Performance
52-week range
Position in day range
METROPOLIS stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹570.01
RSI (14)
80
Overbought zone
Volatility (ATR)
2.46%
Moderate
Close streak
2d up
Volume vs 20d avg
1.01x
From 52W high
-2.31%
Up from 52W low
+44.33%
Green days (20)
12/20
Monthly seasonality
Average monthly move for METROPOLIS across the available price history.
Key statistics
Open
605.15
Day high
607.5
Day low
590.6
Prev close
595
Volume
2.92 L
Avg vol (20d)
2.88 L
52W high
609.05
52W low
412.25
METROPOLIS quarterly results
All METROPOLIS results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹450 cr
+16.6% YoY
Net profit
₹56.67 cr
+25.8% YoY
Operating profit
₹78.79 cr
+33.7% YoY
EPS
₹2.73
+25.8% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹450 cr | ₹78.79 cr | ₹56.67 cr | 17.5% | 12.6% | ₹2.73 | +25.8% | +11.3% |
| Q4 FY262026-03-31 | ₹425 cr | ₹69.43 cr | ₹50.9 cr | 16.3% | 12.0% | ₹2.46 | +74.7% | +23.0% |
| Q3 FY262025-12-31 | ₹406 cr | ₹62.97 cr | ₹41.39 cr | 15.5% | 10.2% | ₹2.00 | — | -8.2% |
| Q1 FY262025-06-30 | ₹386 cr | ₹58.91 cr | ₹45.06 cr | 15.3% | 11.7% | ₹2.17 | — | +54.6% |
| Q4 FY252025-03-31 | ₹345 cr | ₹33.67 cr | ₹29.14 cr | 9.8% | 8.4% | — | — | — |
| TTM (last 4 quarters) | ₹1,667 cr | ₹270 cr | ₹194 cr | 16.2% | 11.6% | ₹9.36 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Latest market news
Canara Hsbc Life Ins Share Price Opens Gap-Down at ₹149.40: What Is Driving CANHLIFE Today, and the Levels That Matter
Canara Hsbc Life Ins (CANHLIFE) trades at ₹152.36, +2.87 (+1.88%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
IPOs Leads the Morning Market Talk on 11 September 2026, Policy And Macro Data and Mutual Funds Close Behind
The most-covered market themes in the morning session on 11 September 2026 — IPOs, policy and macro data, mutual funds — with our live numbers for each and links to the publishers running the story.
Vodafone Idea Share Price Drops 4.16% to ₹14.90: What Is Driving IDEA Today, and the Levels That Matter
Vodafone Idea (IDEA) trades at ₹14.90, -0.62 (-4.16%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Novartis India Share Price Hits 52-Week High, Up 9.96%: What Is Driving NOVARTIND Today, and the Levels That Matter
Novartis India (NOVARTIND) trades at ₹2,428.20, +241.80 (+9.96%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Fino Payments Bank Opens Gap-Down at ₹137.90 — Should Investors Read This as a Trend or a One-Day Move?
Fino Payments Bank (FINOPB) trades at ₹139.65, +2.01 (+1.44%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.